Electron arc dose distributions as a function of beam energy.

The characteristic angle-beta concept provides a simple semiempirical method for determination of dose distributions in electron arc therapy. Initially, the method required a set of measured radial depth dose distributions for each electron beam energy used for arc therapy. In this paper, we report an extension of the angle-beta concept that enables the determination of arc therapy depth doses for an arbitrary electron energy from the known set of depth dose data at a reference energy. Depth dose distributions of stationary and arc electron beams have been studied in the energy range from 9 to 18 MeV. The stationary electron beams used for electron arc therapy were collimated by photon collimators only, no secondary collimation was used in our experiments. For stationary electron beams and for arc electron beams with a given characteristic angle beta, the depths of dose maximum as well as the depths of a given percentage depth dose beyond the depth of dose maximum are linearly proportional to the mean incident electron energy. This simple geometrical and dosimetric relationship increases the potential usefulness of the angle-beta concept in clinical electron arc therapy.

Equivalent square as a predictor of depth of dose maximum for megavoltage therapy beams.

The depths of dose maxima, dmax, and surface doses of 6 MV, 10 MV, and 18 MV photon beams were measured for various square fields and rectangular fields with elongation ratios from 1 to 27. Rectangular fields with elongation ratios below 2 have essentially the same depths of dose maxima and surface doses as their corresponding equivalent square fields. For rectangular fields with elongation ratios above 2, the surface doses increase, and depths of dose maxima decrease with increasing elongation ratio in comparison to their respective values for their corresponding equivalent square fields. The shift of dmax toward the surface is more pronounced when the upper jaws rather than the lower jaws define the long axis of the field. This collimator exchange effect does not influence the surface dose. Even for the largest elongation ratios, the changes in dmax and surface dose from their equivalent square field values were minor and clinically insignificant, suggesting that the equivalent square approach provides a reliable method for predicting the values of dmax and surface dose for rectangular fields from square fields data.

Thermoluminescent dosimetry in electron beams: energy dependence.

The response of thermoluminescent dosimeters to electron irradiations depends on the radiation dose, mean electron energy at the position of the dosimeter in phantom, and the size of the dosimeter. In this paper the semi-empirical expression proposed by Holt et al. [Phys. Med. Biol. 20, 559-570 (1975)] is combined with the calculated electron dose fraction to determine the thermoluminescent dosimetry (TLD) response as a function of the mean electron energy and the dosimeter size. The electron and photon dose fractions, defined as the relative contributions of electrons and bremsstrahlung photons to the total dose for a clinical electron beam, are calculated with Monte Carlo techniques using EGS4. Agreement between the calculated and measured TLD response is very good. We show that the considerable reduction in TLD response per unit dose at low electron energies, i.e., at large depths in phantom, is offset by an ever-increasing relative contribution of bremsstrahlung photons to the total dose of clinical electron beams. This renders the TLD sufficiently reliable for dose measurements over the entire electron depth dose distribution despite the dependence of the TLD response on electron beam energy.